Questions to Ask Before Joining a Special Clinical Program in China

Medical disclaimer: This article is for general information only and is not medical advice. Innovative immunotherapies discussed here (including mRNA-based approaches, peptide therapies, and dendritic cell vaccines) are investigational or available only through regulated clinical programs in specific settings. Suitability must be assessed individually by qualified physicians. Always consult your own oncology team before making treatment decisions.

China has become a destination for patients seeking innovative oncology programs — including cell therapies, cancer vaccines, and other investigational immunotherapies — that may not be available in their home countries. Traveling for treatment adds layers of complexity to an already difficult decision. This article collects the questions international patients should ask before committing to a special clinical program in China.

About the Program Itself

Start with the fundamentals — the same questions you would ask of any experimental program, with China-specific additions:

• What is the exact therapy, and what is its mechanism in plain language?
• Under what regulatory basis does the program operate? Ask for the specific regulation, pilot policy, or approval — in writing. China's system includes national clinical trial regulations as well as regional pilot programs (such as those in designated medical zones); the program should be able to name which framework applies.
• Is there ethics committee approval? Legitimate programs have documented ethics oversight. Ask to see it.
• Is the therapy part of a registered clinical trial? If so, ask for the registration number so you can verify it independently.
• What published evidence supports this specific protocol? Distinguish between general research on the approach and data on this program's actual implementation.

About the Hospital and Physicians

• Is the institution a licensed hospital, and what is its standing in oncology?
• Who are the treating physicians — names, specialties, and experience with this specific therapy?
• Does the hospital have the necessary facilities (for example, certified cell-processing laboratories for cell therapies)?
• What emergency and intensive care capacity is available if serious side effects occur?
• Will you have a named attending physician responsible for your case throughout?

About Eligibility and the Evaluation Process

• What are the inclusion and exclusion criteria? Get them in writing before traveling.
• What medical records are required for the pre-travel evaluation, and who reviews them?
• Is eligibility confirmed before you travel, or only after arrival? A program that asks you to fly first and evaluates later deserves extra scrutiny — clarify what happens (including financially) if you are found ineligible on arrival.
• What fresh tests will be required after arrival, and how long does the evaluation take?

About the Treatment Plan and Safety

• What is the full protocol: doses, schedule, number of cycles, and total expected duration?
• What are the known and potential side effects, and how are they monitored and managed?
• What happens if the disease progresses during treatment — is there a defined stopping rule?
• How does the program coordinate with your home oncology team, and what records will you take home?
• What follow-up is planned after you return home, and who is responsible for it?

About Costs and Payment

Money questions are medical questions too — financial surprises mid-treatment can disrupt care:

• Request an itemized cost breakdown: treatment, hospitalization, tests, medications, and any manufactured products (such as personalized cell preparations).
• Ask what is not included: complications, extended stays, additional cycles, and follow-up care.
• Clarify the payment schedule: what is paid before travel, on arrival, and per cycle — and the refund policy if treatment is stopped early or you are found ineligible.
• Confirm the currency, payment methods accepted, and whether costs are fixed in a written quote.
• Treat any figures as reference ranges: final pricing varies by individual plan — confirm with your actual quote.

About Travel and Logistics

• What visa type do you need, and does the program provide supporting documents such as a treatment invitation letter?
• How long should you plan to stay, including evaluation, treatment, and observation periods?
• What accommodation options exist near the hospital, and does the program assist with booking?
• Is interpretation provided — during consultations, consent discussions, and daily care — and is it included in the cost?
• Can a family member or companion stay with you, including during hospitalization?

About Informed Consent

Before any treatment begins, you should receive — and fully understand — a written informed consent document covering:

• The investigational status of the therapy, stated plainly.
• Known risks and side effects, and what is still unknown.
• Alternative options, including standard care and doing nothing.
• Your right to withdraw at any time without penalty to your ongoing care.
• How your medical data will be used, stored, and protected.

If consent is rushed, only verbal, or unavailable in a language you understand, do not proceed until that is fixed.

A Pre-Travel Checklist

• [ ] Program's regulatory basis and ethics approval confirmed in writing
• [ ] Treating physicians identified with verifiable credentials
• [ ] Eligibility criteria received; pre-travel records review completed
• [ ] Full protocol, schedule, and side-effect management plan in writing
• [ ] Itemized quote with payment schedule and refund terms
• [ ] Visa requirements confirmed; invitation letter received if needed

Medical review note

This article was reviewed by the HuaCure medical content team and is for information only.